p38 MAPK in development and cancer

被引:186
|
作者
Bradham, Cynthia [1 ]
McClay, David R. [1 ]
机构
[1] Duke Univ, DCMB Grp, Durham, NC 27708 USA
关键词
p38; MAPK; embryo; development; cancer; review;
D O I
10.4161/cc.5.8.2685
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
p38 is a MAPK that has been shown to induce a wide variety of biological effects in cell culture in response to a wide range of stimuli. These effects are dependent not only on the stimuli, but also on the cellular context, resulting in a bewildering array of possibilites. For example, p38 was shown to induce apoptosis in some cells, but prevent apoptosis in others. Similarly opposed effects had been observed with respect to cell cycle regulation. The role of p38 in inflammatory disease has been appreciated from the beginning, since it was initially identified as an cytokine inducer. 3 More recently, p38 function has been evaluated in vivo, and through these studies p38 has emerged as an important regulator of both embryonic development and cancer progression. This review will focus on these in vivo studies in an effort to provide perspective on p38 biologically and as a pharmacological target.
引用
收藏
页码:824 / 828
页数:5
相关论文
共 50 条
  • [41] Inhibiting p38α and -β MAPK Affects Testis Development in the Marsupial Tammar Wallaby
    Paranjpe, Monika R.
    Grady, Patrick G. S.
    Yu, Hongshi
    Pask, Andrew J.
    O'Neill, Rachel J.
    Shaw, Geoff
    Renfree, Marilyn B.
    SEXUAL DEVELOPMENT, 2024,
  • [42] Screening and Validation of p38 MAPK Involved in Ovarian Development of Brachymystax lenok
    Huang, Tianqing
    Gu, Wei
    Liu, Enhui
    Zhang, Lanlan
    Dong, Fulin
    He, Xianchen
    Jiao, Wenlong
    Li, Chunyu
    Wang, Bingqian
    Xu, Gefeng
    FRONTIERS IN VETERINARY SCIENCE, 2022, 9
  • [43] Comparative chemical array screening for p38γ/δ MAPK inhibitors using a single gatekeeper residue difference between p38α/β and p38γ/δ
    Kondoh, Yasumitsu
    Honda, Kaori
    Hiranuma, Sayoko
    Hayashi, Teruo
    Shimizu, Takeshi
    Watanabe, Nobumoto
    Osada, Hiroyuki
    SCIENTIFIC REPORTS, 2016, 6
  • [44] The p38 MAPK signaling pathway: A major regulator of skeletal muscle development
    Keren, Aviad
    Tamir, Yael
    Bengal, Eyal
    MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2006, 252 (1-2) : 224 - 230
  • [45] Comparative chemical array screening for p38γ/δ MAPK inhibitors using a single gatekeeper residue difference between p38α/β and p38γ/δ
    Yasumitsu Kondoh
    Kaori Honda
    Sayoko Hiranuma
    Teruo Hayashi
    Takeshi Shimizu
    Nobumoto Watanabe
    Hiroyuki Osada
    Scientific Reports, 6
  • [46] Targeting P38δ MAPK in Oesophageal Cancer: a Possible Future Therapeutic Goal?
    O'Callaghan, C.
    Fanning, L.
    Houston, A.
    Barry, O. P.
    EUROPEAN JOURNAL OF CANCER, 2012, 48 : 173 - 174
  • [47] p38 MAPK Isoforms as Modulators of Oncogenic Phenotypes in Inflammatory Breast Cancer
    Rivera, Jeisac
    Peterson, Esther
    FASEB JOURNAL, 2020, 34
  • [49] Apoptosis induction by p38 MAPK inhibitor in human colon cancer cells
    Tsuchiya, Takeshi
    Tsuno, Nelson H.
    Asakage, Masahiro
    Yamada, Jun
    Yoneyama, Satomi
    Okaji, Yurai
    Sasaki, Shin
    Kitayama, Joji
    Osada, Takuya
    Takahashi, Koki
    Nagawa, Hirokazu
    HEPATO-GASTROENTEROLOGY, 2008, 55 (84) : 930 - 935
  • [50] p38α MAPK pathway: A key factor in colorectal cancer therapy and chemoresistance
    Grossi, Valentina
    Peserico, Alessia
    Tezil, Tugsan
    Simone, Cristiano
    WORLD JOURNAL OF GASTROENTEROLOGY, 2014, 20 (29) : 9744 - 9758